Industries > Pharma > Global Antibacterial Drugs Market 2017-2027

Global Antibacterial Drugs Market 2017-2027

Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others

PUBLISHED: 13 March 2017
PAGES: 304
PRODUCT CODE: PHA0175
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0175 Categories: , Tag:

The global antibacterial drugs market is expected to grow at a CAGR of 1.3% in the first half of the forecast period and a CAGR of 3.1% in the second half of the forecast period. The market is estimated at $41.76bn in 2016 and $44.54bn in 2021.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 304-page report you will receive 124 tables and 97 figures – all unavailable elsewhere.

The 304-page report provides clear detailed insight into the global antibacterial drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Antibacterial Drugs Market 2017-2027

Report Scope
Global Antibacterial Drugs Market forecasts from 2017-2027

• Revenue forecasts for the 6 leading submarkets from 2017-2027:
– Cephalosporins
– Penicillins
– Fluoroquinolones
– Macrolides
– Carbapenems
– Others

• Revenue forecasts for the 43 leading marketed antibacterial drugs from 2017-2027:
– Cephalosporins: Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam
– Penicillins: Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic amoxicllin-clavulanic acid, Amoxil
– Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, Cipro/Ciprobay, Geninax, Defafloxacin
– Macrolides: Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin
– Carbapenems: Invanz, Merrem/Meropen, Primaxin, Doribax
– Other antibacterial drugs: Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin

• Revenue forecasts for the leading developed and emerging national and regional markets. Markets forecasted in this report are the following:
– The US
– The EU: France, Germany, Italy, Spain, the UK, and others
– Japan
– The BRIC countries: Brazil, Russia, India, China
– South Korea
– The Rest of the World

• Analysis of the strengths, weaknesses as well as the opportunities and threats of the antibacterial drugs industry and market

• Coverage of antibacterial drug candidates in the R&D pipeline. Discussions of research and development – see progress in this industry, finding technological, clinical and commercial outlooks and opportunities

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Antibacterial Drugs Market. You find data, trends and predictions.

Buy our report today Global Antibacterial Drugs Market 2017-2027: Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Antibacterial Drugs Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Antibacterial Drugs Market 2017-2027


Latest Pharma news

Visiongain Publishes Biologics Market Report 2020-2030

Biosimilars will be changing the biologics market in the long term. But whether it does it for the better or the worse will depend on how the producers of biologics respond to their market presence.

06 August 2020

READ

Visiongain Publishes Biochips Market Report 2020-2030

Conceptually, it is clear for all stakeholders in the health care segment as well in the biotechnological sector the benefits are evident since it will improve the speed and accuracy of diagnostics or analysis.

05 August 2020

READ

Visiongain Publishes Cell and Gene Supply Chain Services and Solutions Market Report 2020-2030

With the threat of growing number of patients due to the COVID-19 infections, the supply chain trends are looking at a shift with no contact and social distancing policies.

03 August 2020

READ

Visiongain Publishes Advanced Wound Care Market Report 2020-2030

Traditional wound care such as gauze and compression therapies are less effective than active wound care products. Active wound dressings create an environment more suitable for healing.

03 August 2020

READ

Categories

Category